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LETTERS TO THE EDITOR
Repairing Tetralogy of
Fallot—Does Age Matter?
We read with interest the article by Munkhammar et al. (1). The
authors attempted to answer an important question for clinicians
who take care of patients after complete repair of tetralogy of Fallot
(TOF): what are the variables related to the development of
restrictive right ventricular (RV) physiology? Although the authors
examined many possible “determinants for restrictive RV physiol-
ogy,” they “focused on age at repair and its possible association to
later diastolic RV physiology.” Unfortunately, their study design
suffers from serious selection bias and the subsequent analysis is
open to methodologic questions.
An initial selection bias is introduced by including patients from
two hospitals: 27 patients from Lund (1985–1996) and 20 patients
from the Hospital for Sick Children (1994–1996). The variables
related to different institution, surgeon and era (Lund clearly
covers a much wider period) were not explored. Although different
surgical techniques were compared, other important operative
variables such as cardiopulmonary bypass time, aortic cross-clamp
time and myocardial preservation technique were not studied.
A more serious problem in subject selection arises from the
arbitrary selection of only infants (,1 year of age) as the study
group. This is particularly worrisome because the authors find a
major effect of “age” on RV restrictive physiology. We have studied
age at operation for infants and children in California and have
found that the age distribution for complete TOF repair does not
follow a normal distribution (2). In addition, the distribution of
age at TOF repair for subgroups of patients, such as patients with
restrictive RV physiology and patients with nonrestrictive physi-
ology, is unknown. Using 1 year as an arbitrary age cutoff may
select different portions of the distribution curves for restrictive and
nonrestrictive groups, distorting any comparison of mean age
between the two groups. Furthermore, the authors found p , 0.05
for the difference in age at repair for restrictive (mean 0.77 months)
and nonrestrictive (mean 0.64 months) groups. The presentation
of the data as the mean value 6 SD implies that the authors used
the Student t test to compare the ages of the two groups. This
would not be an appropriate comparison if age at repair for TOF
is not normally distributed. In addition, there was a mere difference
of ,2 months (6 months vs. 8 months) in mean age between the
two groups, with a wide standard deviation in both groups, making
the meaning of p , 0.05 by the Student t test questionable.
After comparing preoperative, operative, postoperative and
echocardiographic variables, the only conclusion the authors could
draw was that “restrictive RV physiology is inversely related to age
at repair.” With the selection bias and methodologic problems in
statistics used, we believe the study does not support the conclusion
the authors have reached. The results of this study should be
interpreted with extreme caution by the readers of the Journal.
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REPLY
Thank you for your interest in our paper on right ventricular (RV)
diastolic physiology after tetralogy of Fallot repair (1). We do agree
that the initial selection of patients from two hospitals may cause
problems in data interpretation, which we have stated in the limita-
tions of the study. However, we do not agree that this should
invalidate our results for the following reasons. In two recent studies
we explored several factors characterizing early and mid-term restric-
tive RV physiology after tetralogy repair, including details on cardio-
pulmonary bypass time, aortic cross-clamp time and different myo-
cardial protection (2,3). Surprisingly, none of these factors were
related to subsequent restrictive RV physiology. It is therefore unlikely
that possible differences between the two hospitals in these surgical
factors should influence subsequent diastolic physiology. The wider
period on patients from Lund could represent a methodologic
problem if restrictive RV physiology was related to length of follow-
up. This is not the case; the pattern of diastolic RV physiology does
not change much with time, as we have shown recently (4).
We definitively do not share your view on selecting patients ,1
year of age for the study, even if age is not normally distributed in
these patients. Because age at repair is declining and transannular
patch (TAP) repair usually is needed in infancy, we believe it is of
particular importance to study this well-defined and clinically impor-
tant age group. The selection is not particularly worrisome because we
suggested a relation of restriction to age at repair. What may be
worrisome are the consequenses of early repair on long-term RV
function if early repair subsequenly leads to more pulmonary regur-
gitation. However, we partly share your methodologic comments on
the use of statistics. The comparisons for all patients were done using
the Student t test (Table 1 of our article), requiring that the data have
an approximately normal distribution. The standard deviations for age
and pulmonary stenosis are far below 50% of the mean, thus
suggesting a normal distribution of the data. For data with a standard
deviation .50% of the mean and for data on patient subgroups with
TAP repair, the nonparametric Mann-Whitney U test was used. The
presentation of the data in Table 1 using the mean value 6 SD can be
misleading. Nonrestrictive patients with TAP repair were significantly
younger at repair and had less severe preoperative pulmonary stenosis
analyzed using nonparametric methods. These are the most important
patients to follow because the consequences of nonrestriction may be
more pronounced (3).
We also share your caution in interpreting small differences, which
should be clear by reading our report carefully. Age at repair is not our
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only finding in relation to diastolic RV physiology and should not be
seen in isolation. We strongly believe there is a need to address
possible relations between age at repair and other contributing factors
to subsequent diastolic physiology in larger studies. Unfortunately, so
far, the interest for studies of early repair and diastolic RV function
have been lacking from several large centers.
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REPLY
We appreciate the interest expressed by someone as experienced in
the field of heart diseases and pregnancy as Dr. Oakley (J Am Coll
Cardiol 1999;33:287) concerning our analysis of pulmonary vas-
cular disease (PVD) in pregnant women (1).
We recognized well in advance and clearly stated the limitations of
our analysis of PVD in pregnancy (1). There is plenty of room for
disagreement, because local experiences, successes and failures with
pregnant women who have PVD may differ widely. It is left to the
readers to extrapolate the findings of our study in accordance with
their own institutional practice. The statistical analysis showed that
cesarean section was a significant risk factor in secondary pulmonary
vascular hypertension, but not in the group of patients with Eisen-
menger’s syndrome. When cases of Eisenmenger’s syndrome and
primary and secondary pulmonary vascular hypertension were pooled
together, operative delivery emerged as a strong risk in the univariate
analysis, but as a weaker one in the multivariate analysis (1). We cited
the editorial of Dr. Oakley, who wrote “. . . fetal growth will eventu-
ally fail and the fetus has to be delivered. The safest route is by
cesarean section under general anaesthesia with generous hydration,
avoidance of systemic vasodilation agents, and prompt replacement of
blood loss” (2). With regard to cyanosis in women with low pulmo-
nary pressure, again a position in favor of cesarean section is taken by
Dr. Oakley (2). Thus, the citation, as stated in the editorial, did not
misrepresent the author’s views. Our conclusion was that cesarean
section should be considered a risk (co)factor in parturients with
PVD, and the editorial was cited to express the difference with
Oakley’s opinion on the “safest” route for delivery (1,2).
The link(s) between a single aspect of management and out-
come, except for the late diagnosis and late hospital admission (1),
are missing and nothing seems to be “safe” in pregnant women
with PVD. Of course, it is possible that patients delivered
operatively may have represented more severe cases (less so for
cyanosis but more so for severity of PVD), or that an individual
patient would be much better managed by some other techniques
or strategies than those actually used. The retrospective overview
showed that timing and mode of delivery could not differentiate
between maternal survival and death in Eisenmenger’s syndrome
(1). We agree that conclusions drawn from an overview of the
published data can be misleading. False conclusions may be drawn
from case reports, prospective randomized studies or editorials. If
we made the same mistake as made by Gleicher et al. (3) in their
classic paper on Eisenmenger’s syndrome and pregnancy in
1979, so be it, we take it as a compliment. Dr. Oakley ends by
questioning our personal experiences in these matters. Clinical
experiences are never visible in the quotations.
In the meantime, as has been the case over the past 50 years (1,3),
pregnant women with Eisenmenger’s syndrome continue to survive or
die independently of vaginal or operative delivery, general or regional
anesthesia and, unfortunately, despite the availability of new pulmo-
nary vasodilators (4–9). At the maternal mortality rate of 30% to 50%,
the “safest” route of management of pregnant women with Eisen-
menger’s syndrome still remains to be defined.
[Dr. Weiss’s reply to Dr. Oakley was received February 26,
1999. We regret the delay in publishing this reply.]
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